This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Issue Summary

Joint health ingredients and products are not seeing the robust sales growth of previous years; however, unique positioning and formulations are still a draw, as are products geared toward an expanding senior demographic. Ingredients such as omega-3s, chondroitin, glucosamine, collagen, eggshell membrane and curcumin are supported by clinical research, but brand holders must use caution to follow regulatory guidelines and draw from sound science when highlighting claims in their marketing efforts.

Table of Contents

  • Viewpoint: Support for Joint Support
    by Rachel Adams
  • Keeping Joints Moving With Ingredients That Target Inflammation
    by Courtney Johnson
  • Joint Health Clinical Trial Nonsense
    by Micah Osborne
  • Joint Health Market Poised for Growth, but Still Struggling
    by Rachel Adams
  • Joint Health Claims, Education and Requirements
    by Jim Lassiter
  • Leaders and Trends in Joint Health Product Intellectual Property
    by Andreas Baltatzis and Gideon Eckhouse
  • SupplySide & Vitafoods Global Storefronts Directory

Takeaways for Your Business

  • Joint health supplement sales rose 6.5 percent in the U.S. natural channel from 2015 to 2016.
  • Maintaining a claims substantiation dossier can aid brand holders in compliance preparedness.
  • Patents and trademarks can help protect joint health intellectual property (IP).